CXCR4 protein epitope mimetic antagonist POL5551 disrupts metastasis and enhances chemotherapy effect in triple-negative breast cancer
- Jingyu Xiang
- , Michelle A. Hurchla
- , Francesca Fontana
- , Xinming Su
- , Sarah R. Amend
- , Alison K. Esser
- , Garry J. Douglas
- , Chidananda Mudalagiriyappa
- , Kathryn E. Luker
- , Timothy Pluard
- , Foluso O. Ademuyiwa
- , Barbara Romagnoli
- , Gérald Tuffin
- , Eric Chevalier
- , Gary D. Luker
- , Michael Bauer
- , Johann Zimmermann
- , Rebecca L. Aft
- , Klaus Dembowsky
- , Katherine N. Weilbaecher
- Section of Medical Oncology
- Bursky Center for Human Immunology and Immunotherapy
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Section of Molecular Oncology & Developmental Therapeutics
- Section of Surgical Oncology
- Division of Cardiology
- DBBS - Molecular Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- Section of Hematological Malignancies
- Mentorship to Enhance Development in Academia Program
Research output: Contribution to journal › Article › peer-review
59
Link opens in a new tab
Scopus
citations